Quality market surveillance

General Lab. and Pharma. Lab. participate In proficiency-testing studies and market surveillance studies organised by European Department for Quality of... 

Post-marketing surveillance of product quality is carried out by means of a QC system. The quality of products available on the market is therefore an important indication of the effectiveness (or otherwise) of the dmg regulatory system. 

Besides the medicine adverse event monitoring, a medicine quality defect reporting system is operated as part of the post-marketing surveillance in Hungary (Bayer 1984, Paal 1988). All phcirmacists working for medicine supply companies or in community and hospital pharmacies have the obligation to report suspected medicine qucility defects to the NIP. These reports are evaluated in close collabo-... 

Drug registration, coupled with efficient and effective post-marketing surveillance, provide the Ministry of Heeilth with a means to control the quality, safety and efficacy with the introduction of medicinal products into Singapore. Drug registration also provides for a more effective system of product recall in cases of detection of defective or drugs harmful to public health. 

Phase IV clinical trials are post-marketing approval trials to monitor the efficacy and side effects of the drug in an uncontrolled real-life situation. This is also known as a post-market surveillance trial. Information about the effectiveness of the drug compared with established treatment, side effects, patient7s quality of life, and cost-effectiveness is collated. 

Quality is affected at every stage of the industrial cycle i.e., during new design, control incoming materials, production control, and post marketing surveillance activities. 

Product Quality versus Factory Quality 65 Consultants Benefits and Limitations 68 U.S. and EU Differences 69 The Quality and Safety Mindset 75 Market Surveillance 76 Enforcement 77... 

The third component of the FDA CDER is the Office of Surveillance and Epidemiology. This group is responsible for ongoing reviews of product safety, efficacy, and quality. It accomplishes this goal by performing statistical analysis of adverse event data it receives to determine whether there is a safety problem. This office reassesses risks based on new data learned after a drug is marketed and recommends... 

Test sample products for conformity and award Approval Marks, with ongoing surveillance of production, to visibly demonstrate product quality and increase marketing advantage. 

---